• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非多托嗪对大鼠腹膜刺激诱导肠梗阻的逆转作用:对感觉传入神经可能的外周作用

Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.

作者信息

Riviere P J, Pascaud X, Chevalier E, Junien J L

机构信息

Institut de Recherche Jouveinal, Fresnes, France.

出版信息

J Pharmacol Exp Ther. 1994 Sep;270(3):846-50.

PMID:7932195
Abstract

Two kappa agonists, fedotozine and trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolydinyl)-cyclohexyl ]- benzeneacetamide methanesulfonate [(+/-)U-50,488H] were used to reverse the gastrointestinal transit inhibition induced by either peritoneal irritation (PI) or intracisternal (i.c.) administration of corticotropin releasing factor (CRF). PI was induced by acetic acid given i.p. Gastric emptying and intestinal transit were estimated with a 51Cr-labeled test meal. PI inhibited both gastric emptying (-50.9%) and intestinal transit (-48.8%). These inhibitions were prevented in a dose-dependent manner by the CRF antagonist, alpha-helical-CRF9-41 at doses (1-10 nmol/rat i.c.) that had no effect in control animals. CRF (300 pmol/rat i.c.) reproduced the gastrointestinal transit inhibitions seen under PI. The CRF effects were blocked by alpha-helical-CRF9-41 (10 nmol/rat) given i.c. but not i.v. Fedotozine (1-10 mg/kg s.c. but not 300 micrograms/rat i.c.v. or intrathecally) and (+/-)U-50,488H (0.3-3 mg/kg s.c. but not 100 micrograms/kg i.c.v.) reversed PI- but not CRF-induced ileus. Neither PI-induced ileus nor the fedotozine response was affected by perivagal capsaicin treatment. It was concluded that the PI-induced ileus depends on central CRF receptors. This result is consistent with the activation of an extrinsic inhibitory reflex. The reversal by kappa agonists of PI- but not CRF-induced ileus suggests that kappa agonists do not act after but before the CRF receptors. A possible peripheral action on nonvagal sensory afferents is suggested.

摘要

使用两种κ激动剂,即非多托嗪和反式-(±)-3,4-二氯-N-甲基-N-[2-(1-吡咯烷基)-环己基]-苯乙酰胺甲磺酸盐[(±)U-50,488H],来逆转由腹膜刺激(PI)或脑池内(i.c.)注射促肾上腺皮质激素释放因子(CRF)所诱导的胃肠运输抑制。PI通过腹腔注射乙酸诱导产生。用51Cr标记的试验餐评估胃排空和肠运输。PI抑制胃排空(-50.9%)和肠运输(-48.8%)。这些抑制作用在剂量依赖的方式下被CRF拮抗剂α-螺旋-CRF9-41(1-10 nmol/大鼠i.c.)所阻止,该剂量对对照动物无影响。CRF(300 pmol/大鼠i.c.)重现了PI条件下所见的胃肠运输抑制。CRF的作用被i.c.而非i.v.给予的α-螺旋-CRF9-41(10 nmol/大鼠)所阻断。非多托嗪(1-10 mg/kg s.c.,但300μg/大鼠i.c.v.或鞘内注射无效)和(±)U-50,488H(0.3-3 mg/kg s.c.,但100μg/kg i.c.v.无效)逆转了PI诱导的肠梗阻,但未逆转CRF诱导的肠梗阻。迷走神经周围辣椒素处理对PI诱导的肠梗阻和非多托嗪反应均无影响。得出的结论是,PI诱导的肠梗阻依赖于中枢CRF受体。该结果与一种外在抑制反射的激活一致。κ激动剂逆转PI诱导而非CRF诱导的肠梗阻表明,κ激动剂并非在CRF受体之后起作用,而是在其之前起作用。提示其可能对非迷走感觉传入神经有外周作用。

相似文献

1
Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.非多托嗪对大鼠腹膜刺激诱导肠梗阻的逆转作用:对感觉传入神经可能的外周作用
J Pharmacol Exp Ther. 1994 Sep;270(3):846-50.
2
Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral kappa-opioid receptors.
Gastroenterology. 1993 Mar;104(3):724-31. doi: 10.1016/0016-5085(93)91007-5.
3
Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.外周注射一种新的促肾上腺皮质激素释放因子(CRF)拮抗剂——阿斯特辛,可阻断外周CRF和腹部手术诱导的大鼠胃排空延迟。
J Pharmacol Exp Ther. 1999 Aug;290(2):629-34.
4
Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.束缚应激通过中枢促肾上腺皮质激素释放因子和外周5-羟色胺3受体刺激清醒大鼠的结肠运动。
Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1037-44. doi: 10.1152/ajpgi.00419.2006. Epub 2006 Dec 7.
5
Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.向中枢注射一种新的促肾上腺皮质激素释放因子(CRF)拮抗剂——抗应激素,可阻断与CRF和应激相关的胃和结肠运动功能改变。
J Pharmacol Exp Ther. 1997 Feb;280(2):754-60.
6
Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.κ受体激动剂可抑制恒河猴的胃排空,但不影响胃酸分泌。
J Pharmacol Exp Ther. 1990 Jun;253(3):1010-6.
7
Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.人尿皮质素II,一种新的促肾上腺皮质激素释放因子相关肽,对大鼠胃排空显示出选择性的促肾上腺皮质激素释放因子(2)介导的作用。
Am J Physiol Gastrointest Liver Physiol. 2002 Jan;282(1):G34-40. doi: 10.1152/ajpgi.00283.2001.
8
Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.两种促肾上腺皮质激素释放因子拮抗剂的药理学比较:体内和体外研究
J Pharmacol Exp Ther. 1994 Jan;268(1):359-65.
9
Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.外周κ-阿片受体介导了非多托嗪(费多托嗪校正)对大鼠十二指肠疼痛反射的镇痛作用。
Eur J Pharmacol. 1994 Dec 12;271(1):65-71. doi: 10.1016/0014-2999(94)90265-8.
10
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
Life Sci. 1997;60(9):625-34. doi: 10.1016/s0024-3205(96)00647-9.

引用本文的文献

1
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.κ阿片受体:多种病症的一个有前景的治疗靶点。
Front Pharmacol. 2022 Jun 20;13:837671. doi: 10.3389/fphar.2022.837671. eCollection 2022.
2
Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.脑与肠促肾上腺皮质激素释放因子信号传导:生物学作用及其在胃肠道中的作用
Curr Mol Pharmacol. 2018;11(1):51-71. doi: 10.2174/1874467210666170224095741.
3
Peripheral kappa-opioid agonists for visceral pain.用于内脏痛的外周κ-阿片受体激动剂。
Br J Pharmacol. 2004 Apr;141(8):1331-4. doi: 10.1038/sj.bjp.0705763. Epub 2004 Mar 29.
4
Recent developments in chest pain of undetermined origin.不明原因胸痛的最新进展。
Curr Gastroenterol Rep. 2000 Jun;2(3):201-9. doi: 10.1007/s11894-000-0062-4.
5
Regional quantitation of preprodynorphin mRNA in guinea pig gastrointestinal tract.
Neurochem Res. 1998 Apr;23(4):505-11. doi: 10.1023/a:1022426400545.
6
Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.外周κ激动剂非多托嗪与安慰剂治疗肠易激综合征的疗效比较:一项多中心剂量反应研究
Dig Dis Sci. 1995 Oct;40(10):2244-9. doi: 10.1007/BF02209014.